๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Alanine - Medicines in Ireland

19 authorised products containing Alanine, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 19 authorised medicines
MedicineActive substanceLicence holderStatus
Finomel Emulsion for Infusion
PA2299/044/002
Glycine, Alanine, Arginine, Histidine, Isoleucine Baxter Holding B.V. Marketed
Finomel Peri Emulsion for Infusion
PA2299/044/001
Alanine, Arginine, Glycine, Histidine, Isoleucine Baxter Holding B.V. Marketed
Kabiven emulsion for infusion
PA2059/045/003
Soya bean oil, Glucose monohydrate, Alanine, Arginine, Aspartic Acid Fresenius Kabi Deutschland GmbH Marketed
Kabiven Peripheral emulsion for infusion
PA2059/045/004
Soya bean oil, Alanine, Aspartic Acid, Glutamic acid, Glycine Fresenius Kabi Deutschland GmbH Marketed
Maapliv solution for infusion
EU/1/25/1955/001
Alanine, Arginine, Aspartic Acid, Cysteine hydrochloride monohydrate, Glutamic acid Recordati Rare Diseases โ€”
Numeta G13%E Preterm emulsion for infusion
PA2299/030/003
Alanine, Arginine, Aspartic Acid, Cysteine, Glutamic acid Baxter Holding B.V. Marketed
Numeta G16%E emulsion for infusion
PA2299/030/001
Alanine, Arginine, Aspartic Acid, Cysteine, Glutamic acid Baxter Holding B.V. Marketed
SmofKabiven extra Nitrogen Electrolyte free, emulsion for infusion
PA2059/060/002
Alanine, Arginine, Glycine, Histidine, Isoleucine Fresenius Kabi Deutschland GmbH Not marketed
SmofKabiven Low Osmo Peripheral emulsion for infusion
PA2059/022/001
Alanine, Arginine, Glycine, Histidine, Isoleucine Fresenius Kabi Deutschland GmbH Not marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion
PA2299/043/007
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine Baxter Holding B.V. Marketed
TRIOMEL 12 g/l nitrogen 950 kcal/l, emulsion for infusion
PA2299/043/008
Alanine, Arginine, Aspartic Acid, Glutamic acid, Glycine Baxter Holding B.V. Marketed
Triomel 5g/L nitrogen 990kcal/L with electrolytes, emulsion for infusion
PA2299/029/002
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Triomel 7g/L nitrogen 1140kcal/L emulsion for infusion
PA2299/029/004
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Triomel 7g/L nitrogen 1140kcal/L with electrolytes emulsion for infusion
PA2299/029/003
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Triomel 9g/L nitrogen 1070kcal/L emulsion for infusion
PA2299/029/006
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Triomel 9g/L nitrogen 1070kcal/L with electrolytes emulsion for infusion
PA2299/029/005
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Triomel Peripheral 4 g/L nitrogen 700 kcal/L with electrolytes emulsion for infusion
PA2299/029/001
Refined olive oil + refined soybean oil, Alanine, Arginine, Aspartic Acid, Glutamic acid Baxter Holding B.V. Marketed
Vaminolact solution for infusion, 100 ml bottle
PA2059/065/001
Alanine, Arginine, Aspartic Acid, Cysteine, Glutamic acid Fresenius Kabi Deutschland GmbH Not marketed
Vaminolact solution for infusion, 500 ml bottle
PA2059/065/002
Alanine, Arginine, Aspartic Acid, Cysteine, Glutamic acid Fresenius Kabi Deutschland GmbH Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.